Introducing: Testing Our Patients Testing Our Patients

Testing Our Patients is a limited discussion series about how life-saving diagnostic tests and breakthrough medicines for cancer patients are considered by the FDA for public access—and how two divergent schools of thought often collide: the risk/reward of rushing approvals too soon vs. the patient advocates who decry, "What's taking so long? We just want to live."